Pay in 4 interest-free payments of $31.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
PD173074 treatment potently reduces viability of FGFR3-expressing KMS11 and KMS18 cells with IC50 of <20 nM
Drug therapy
transplantation and allograft rejection
which is currently under clinical trial for Alzheimer's disease
Pixantrone (25 or 100 nM) induces severe chromosomal aberrations and mitotic catastrophe in PANC1 cells
Rapastinel Catalog No.:M13065-2 PD173074 treatment potently reduces viabilityRapastinel (GLYX 13) is an N methyl D aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist. Target: NMDA Rapastinel is a robust cognitive enhancer and facilitates hippocampal long term potentiation (LTP) of synaptic transmission in slices. Product information CAS Number: 117928 94 6 Molecular Weight: 413. 47 Formula: C18H31N5O6 Synonym: GLYX 13 Chemical Name: (2S,3R) 2 {[(2S) 1 [(2S) 1 [(2S,3R) 2 amino 3
US$ 1035.49
US$ 107.95
US$ 120.99
US$ 1610.49